Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen (Q85216712)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 19, 2010

Language	Label	Description	Also known as
English	Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen	scientific article published on October 19, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957430%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957430%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

immunohistochemistry

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

immunologic adjuvant

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

object named as

Olle Stål

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957430%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

7

object named as

Jonas Bergh

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20957430

5 August 2024

author name string

Britta Löfdahl

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957430%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Helena Fohlin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957430%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Tommy Fornander

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957430%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Lambert Skoog

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957430%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Bo Nordenskjöld

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957430%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Mahmoud R. Khoshnoud

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20957430

5 August 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20957430

5 August 2024

publication date

19 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957430%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

full work available at URL

https://hal.archives-ouvertes.fr/hal-00586983/file/PEER_stage2_10.1007%252Fs10549-010-1202-7.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20957430

5 August 2024

http://link.springer.com/content/pdf/10.1007/s10549-010-1202-7.pdf

Portable Document Format

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

http://link.springer.com/article/10.1007/s10549-010-1202-7/fulltext.html

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

http://link.springer.com/content/pdf/10.1007/s10549-010-1202-7

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957430%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

126

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957430%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957430%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

421-430

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20957430%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

1

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

3

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Estrogen receptors and long-term prognosis in breast cancer

7

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Prognostic factors. Stage and receptor status in breast cancer

8

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

9

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen

10

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival

11

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Comparison of immunohistochemical and biochemical measurement of steroid receptors in primary breast cancer: evaluation of discordant findings

12

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases

13

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Comparison of immunohistochemical and biochemical assay of steroid receptors in primary breast cancer--clinical associations and reasons for discrepancies

14

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC)

15

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods

16

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma

17

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.

19

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect

20

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Isoelectric focusing of estradiol receptor protein from human mammary carcinoma - a comparison to sucrose gradient analysis

21

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Cytosol estradiol receptor in human mammary carcinoma: An assay based on isoelectric focusing in polyacrylamide gel

22

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Enzyme immuno assay of the estrogen receptor in breast cancer biopsy samples. A comparison with isoelectric focusing

24

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid

25

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data

26

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer

27

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Adjuvant tamoxifen therapy and receptor levels

28

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Oestrogen receptor analysis of paraffin sections and cytosol samples of primary breast cancer in relation to outcome after adjuvant tamoxifen treatment. The South Sweden Breast Cancer Group

30

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

31

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer

32

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

33

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

34

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

35

1 reference

10.1007/S10549-010-1202-7

https://api.crossref.org/works/10.1007/S10549-010-1202-7

5 August 2024

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85216712&oldid=2222946031"